Prosecution Insights
Last updated: April 19, 2026

Examiner: SELWANES, JOHN PAUL

Tech Center 1600 • Art Units: 1651 1657

This examiner grants 45% of resolved cases

Performance Statistics

44.8%
Allow Rate
-15.2% vs TC avg
94
Total Applications
+61.7%
Interview Lift
1345
Avg Prosecution Days
Based on 58 resolved cases, 2023–2026

Rejection Statute Breakdown

9.2%
§101 Eligibility
12.8%
§102 Novelty
37.4%
§103 Obviousness
31.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17159870 FUNGAL SPECIES, COMPOSITIONS DERIVED THEREFROM, AND USES THEREOF Non-Final OA President and Fellows of Harvard College
17617285 SYSTEMS COMPRISING SUBSTRATES AND METHODS OF USING THE SAME FOR DETECTION OF PANCREATIC CANCERS Final Rejection THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
17607718 INDUSTRIAL FERMENTATION PROCESS FOR MICROBIAL CELLS USING A FED-BATCH PRE-CULTURE Non-Final OA BASF SE
17312172 METHODS, COMPOSITIONS, AND MEDIA FOR IMPROVING PLANT TRAITS Non-Final OA Pivot Bio, Inc.
18441878 E3 UBIQUITIN LIGASE (UBE3A) PROTEIN TARGETS Non-Final OA Hoffmann-La Roche Inc.
17331723 ELECTROANALYTICAL DETERMINATION OF LEUKOCYTE ESTERASE Non-Final OA Board of Regents, the University of Texas System
17796769 A METHOD FOR ISOLATING A MICROORGANISM Non-Final OA TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
17767619 NON-INVASIVE METHOD FOR DETECTION OF ENZYME ACTIVITY IN VIVO, SUBSTRATES AND A DEVICE THEREFORE Non-Final OA ETH ZURICH
16766189 Small Enzyme Particles For Interesterification Non-Final OA Novozymes A/S
14124535 Spray-Dried Lactobacillus Stems/Cells and the Use of Same Against Helicobacter Pylori Final Rejection NOVOZYMES A/S
17920142 METHOD AND DEVICE FOR ASSESSING A STATUS OF A WOUND OF A PATIENT Non-Final OA PAUL HARTMANN AG
17280882 Multi-Use Fermentation Products Obtained Through Production of Sophorolipids Non-Final OA Locus Solutions IPCo, LLC
18689550 PREPARATION METHOD OF ECHINOCANDIN NUCLEUS Non-Final OA BIOCON LIMITED
17639729 Production of Sialylated Oligosaccharides in Bacillus Cells Non-Final OA Chr. Hansen A/S
17054950 USE OF GLYCOSIDASES IN THE PRODUCTION OF OLIGOSACCHARIDES Final Rejection Chr. Hansen A/S
18560260 ENZYMES, HOST CELLS, AND METHODS FOR PRODUCTION OF ROTUNDONE AND OTHER TERPENOIDS Non-Final OA MANUS BIO INC.
18315169 PROCESS FOR THE RECOVERY OF MICROALGAE USING MAGNETIC NANOPARTICLES OF BACTERIAL ORIGIN Non-Final OA UNIVERSIDADE FEDERAL DO RIO DE JANEIRO
18284708 METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE AND ENZYME USED FOR THE SAME Non-Final OA MicroBiopharm Japan Co., Ltd.
16816009 COMPOSITIONS, KITS, AND METHODS FOR DETECTING AUTOANTIBODIES Final Rejection Quidel Corporation
17800728 Biomarker for Predicting Prognosis of Radiotherapy for Lung Cancer Final Rejection Korea Institute of Radiological & Medical Sciences
17907162 NON INVASIVE METHODS FOR DIAGNOSING LIVER FIBROSIS Final Rejection King's College Hospital NHS Foundation Trust
17608255 RESPIRATORY INFECTION DETECTION AND CLASSIFICATION Non-Final OA AROCELL AB
17314502 METHOD, DEVICE, AND KIT FOR POPULATION SCREENING FOR CANCER, CANCER RECURRENCE AND PRECANCEROUS CONDITIONS IN SYMPTOM FREE INDIVIDUALS Non-Final OA CANCER PREVENTION, LLC
17276142 METHOD FOR CULTIVATING A MICROORGANISM OF INTEREST AND ASSOCIATED FACILITY Final Rejection KYANOS BIOTECHNOLOGIES
16965324 PLANT MICROBIAL PREPARATIONS, COMPOSITIONS AND FORMULATIONS COMPRISING SAME AND USES THEREOF Non-Final OA Lavie Bio Ltd
16614321 MINERAL BENEFICIATION METHOD USING BIOREAGENT EXTRACTED FROM GRAM POSITIVE BACTERIA Final Rejection ASSOCIAÇÃO INSTITUTO TECNOLÓGICO VALE – ITV
15766558 PROBIOTIC FORMULATION Final Rejection Bifodan A/S

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month